MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE PROPATEN VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT

Model Number HT087080A

Device Problem Material Separation (1562)

Patient Problem Death (1802)

Event Date 01/14/2020

Event Type  Death  

Manufacturer Narrative

A review of the manufacturing records indicated the device met pre-release specifications.The device was not returned for an engineering evaluation.Consequently, a direct product analysis was not possible.Additional information about this event could not be obtained.As a result, no further investigation is possible.

Event Description

The following was reported to gore: on (b)(4) 2019 an 8mm gore® propaten® vascular graft was implanted as a bypass, common iliac to distal sfa.On (b)(6) 2020 the physician performed a re-exploration as a result of an identified occlusion within the graft.The doctor performed a graft thrombectomy as well as revision of the distal anastomosis, extending treatment by sewing a second graft to the distal anastomosis to the popliteal below knee position.On (b)(6) the graft to graft anastomosis disrupted.According to the doctor, the patient bled out very rapidly and expired.

Manufacturer Narrative

Additional manufacturer narrative: 2 devices were reported to gore.Reference medwatch 2017233-2020-00132 for other device.

Manufacturer Narrative

The following engineering evaluation was performed with no devices returned to w.L.Gore & associates: two device serial numbers associated with this event were provided, but the identity of the associated devices could not be confirmed.Md142775, gore-tex® vascular graft and gore® propaten® vascular graft process failure modes and effects analysis (pfmea), revision 9 was reviewed for process steps with suture line disruption as a potential device failure mode or occlusion as a potential hazardous situation.Process steps identified span the component/kitting processes in medical west, the heparin coatings/cutting/packaging processes in kendrick peak, and the boxing process in fisher point.All device history records associated with both device serial numbers were reviewed across all aforementioned processes.All appropriate signatures and other evidence of process conformation were verified.The event description could not be confirmed with the information provided.The reported codes reflect the event description, but cannot be confirmed.Additional devices included on this report are as follows: item #h080040a/ lot #6299684pp033, which is captured in manufacturer report #2017233-2020-00132.

Manufacturer Narrative

B3, date of event - updated to (b)(6) 2020.

Manufacturer Narrative

Additional manufacturing narrative: c1.Name (#1) cbas® heparin surface.Manufacturer/compounder: w.L.Gore & associates, inc., lot #5918388pp019.Cbas® heparin surface incorporates, cbas-heparin manufactured from heparin sodium api, which is covalently bound to the device surface.And is essentially non-eluting.

• Brand Name: GORE PROPATEN VASCULAR GRAFT
• Type of Device: PROSTHESIS, VASCULAR GRAFT
• Manufacturer (Section D): W.L. GORE & ASSOCIATES; flagstaff AZ
• MDR Report Key: 9689891
• MDR Text Key: 178501510
• Report Number: 2017233-2020-00082
• Device Sequence Number: 1
• Product Code: DSY
• UDI-Device Identifier: 00733132606849
• UDI-Public: 00733132606849
• Combination Product (y/n): N
• PMA/PMN Number: K062161
• Number of Events Reported: 1
• Summary Report (Y/N): N
• Report Source: Manufacturer
• Source Type: company representative
• Type of Report: Initial,Followup,Followup,Followup,Followup
• Report Date: 07/30/2020

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: Yes
• Is this a Product Problem Report?: Yes
• Device Operator: Health Professional
• Device Expiration Date: 04/19/2022
• Device Model Number: HT087080A
• Device Catalogue Number: HT087080A
• Device Lot Number: 5918388PP019
• Was Device Available for Evaluation?: No
• Was the Report Sent to FDA?: No
• Initial Date Manufacturer Received: Not provided
• Initial Date FDA Received: 02/10/2020
• Supplement Dates Manufacturer Received: Not provided; Not provided; Not provided; Not provided
• Supplement Dates FDA Received: 02/27/2020; 05/12/2020; 05/19/2020; 07/30/2020
• Is This a Reprocessed and Reused Single-Use Device?: No
• Patient Sequence Number: 1
• Patient Outcome(s): Death
• Patient Age: 53 YR
• Patient Weight: 70